AlzeCure Pharma CEO to present company update at Aktiespararna investor evening
Bitget2026/10/08 08:02AlzeCure Pharma will present at Aktiespararna’s investor evening in Stockholm on Oct. 14. CEO Martin Jönsson is set to brief investors on the portfolio, including recent collaboration and outlicensing deals with Eli Lilly. The session starts at 18:00 CEST at Medborgarskolan on Hagagatan 23 A. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AlzeCure Pharma AB published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.
- AlzeCure Pharma will present at Aktiespararna’s investor evening in Stockholm on Oct. 14.
- CEO Martin Jönsson is set to brief investors on the portfolio, including recent collaboration and outlicensing deals with Eli Lilly.
- The session starts at 18:00 CEST at Medborgarskolan on Hagagatan 23 A.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Crypto prices
More
